Treatment outcomes of molecular targeted therapy following nivolumab in metastatic renal cell carcinoma

Y Bando, J Furukawa, T Terakawa… - Japanese Journal of …, 2021 - academic.oup.com
Objective The purpose of this study was to assess the therapeutic efficacy of molecular
targeted therapies following nivolumab in metastatic renal cell carcinoma and to examine …

Treatment outcomes of molecular targeted therapy following nivolumab in metastatic renal cell carcinoma

Y Bando, J Furukawa, T Terakawa… - … journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Objective The purpose of this study was to assess the therapeutic efficacy of molecular
targeted therapies following nivolumab in metastatic renal cell carcinoma and to examine …

Treatment outcomes of molecular targeted therapy following nivolumab in metastatic renal cell carcinoma.

Y Bando, J Furukawa, T Terakawa… - Japanese Journal of …, 2021 - europepmc.org
Objective The purpose of this study was to assess the therapeutic efficacy of molecular
targeted therapies following nivolumab in metastatic renal cell carcinoma and to examine …

Treatment outcomes of molecular targeted therapy following nivolumab in metastatic renal cell carcinoma

Y Bando, J Furukawa, T Terakawa… - Japanese Journal of …, 2021 - academic.oup.com
Objective The purpose of this study was to assess the therapeutic efficacy of molecular
targeted therapies following nivolumab in metastatic renal cell carcinoma and to examine …

Treatment outcomes of molecular targeted therapy following nivolumab in metastatic renal cell carcinoma

Y Bando, J Furukawa, T Terakawa, K Harada… - Japanese Journal of …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Objective</jats: title>< jats: p>
The purpose of this study was to assess the therapeutic efficacy of molecular targeted …

Treatment outcomes of molecular targeted therapy following nivolumab in metastatic renal cell carcinoma.

Y Bando, J Furukawa, T Terakawa… - … Journal of Clinical …, 2021 - search.ebscohost.com
Objective The purpose of this study was to assess the therapeutic efficacy of molecular
targeted therapies following nivolumab in metastatic renal cell carcinoma and to examine …